DRUG ELUTING BALLOON FOR THE TREATMENT OF PERIPHERAL ARTERY DISEASE: A COST-EFFECTIVENESS ANALYSIS IN ITALY

被引：0
|
作者：
Giardina, S. [1 ]
Brasseur, P. [2 ]
Busca, R. [2 ]
Micari, A. [3 ]
机构：
[1] Medtron Italy SPA, Sesto San Giovanni, Italy
[2] Medtron Int Trading Sarl, Tolochenaz, Switzerland
[3] Villa Maria Eleonora Hosp, Palermo, Italy
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.153
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A259 / A259
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of Drug-eluting Stents in Patients With Stable Coronary Artery Disease
    Hung, Chi-Sheng
    Cheng, Chia-Ling
    Chao, Chia-Lun
    Kao, Hsien-Li
    Chen, Ming-Fong
    Lin, Neng-Pai
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2011, 110 (02) : 109 - 114
  • [2] COST EFFECTIVENESS OF DRUG ELUTING BALLOON VERSUS PERCUTANEOUS TRANSLUMINAL BALLOON ANGIOPLASTY, BARE METAL STENT AND DRUG ELUTING STENT IN THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE IN LOWER LIMBS COLOMBIA
    Orozco, J. J.
    Valencia, J. E.
    Sardi, C.
    VALUE IN HEALTH, 2014, 17 (03) : A113 - A114
  • [3] COST-EFFECTIVENESS OF CORONARY AND PERIPHERAL ARTERY DISEASE TREATMENTS
    Soini, E.
    Virtanen, O.
    Briere, J. B.
    Bowrin, K.
    Millier, A.
    VALUE IN HEALTH, 2019, 22 : S546 - S546
  • [4] Drug-eluting stent, drug eluting balloon controversy in peripheral artery disease; what is the verdict?
    Kilic, Ismail Dogu
    Cilingiroglu, Mehmet
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (06) : 1315 - 1316
  • [5] COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY ARTERY DISEASE OR PERIPHERAL ARTERY DISEASE IN SPAIN
    Gonzalez-Juanatey, J. R.
    Gomez, J. J.
    Lozano, F. S.
    Valle, A.
    Bowrin, K.
    Briere, J. B.
    Llorac, A.
    Millier, A.
    de Miguel, C.
    Diana, N.
    VALUE IN HEALTH, 2020, 23 : S493 - S494
  • [6] Cost-Effectiveness Analysis of Infrapopliteal Drug-Eluting Stents
    Konstantinos Katsanos
    Dimitris Karnabatidis
    Athanasios Diamantopoulos
    Stavros Spiliopoulos
    Dimitris Siablis
    CardioVascular and Interventional Radiology, 2013, 36 : 90 - 97
  • [7] Cost-Effectiveness Analysis of Infrapopliteal Drug-Eluting Stents
    Katsanos, Konstantinos
    Karnabatidis, Dimitris
    Diamantopoulos, Athanasios
    Spiliopoulos, Stavros
    Siablis, Dimitris
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 36 (01) : 90 - 97
  • [8] Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test
    Itoga, Nathan K.
    Minami, Hataka R.
    Chelvakumar, Meenadachi
    Pearson, Keon
    Mell, Matthew M.
    Bendavid, Eran
    Owens, Douglas K.
    VASCULAR MEDICINE, 2018, 23 (02) : 97 - 106
  • [9] Cost-effectiveness analysis of asymptomatic peripheral artery disease screening in primary care
    Ferrat, Emilie
    Moreau, Alain
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2015, 26 (118): : 6S - 7S
  • [10] Cost-effectiveness of urokinase and alteplase for treatment of acute peripheral artery disease: Comparison in a decision analysis model
    Olvey, Eleanor L.
    Skrepnek, Grant H.
    Nolan, Paul E., Jr.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (15) : 1435 - 1442
12345